Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,869 | 269 | 98.3% |
| Education | $65.00 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $572.83 | 35 | $0 (2019) |
| PFIZER INC. | $296.92 | 29 | $0 (2019) |
| Novo Nordisk Inc | $265.65 | 19 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $237.78 | 20 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $236.40 | 18 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $212.91 | 14 | $0 (2019) |
| Amgen Inc. | $200.06 | 14 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $174.07 | 13 | $0 (2017) |
| Astellas Pharma US Inc | $164.44 | 8 | $0 (2019) |
| GlaxoSmithKline, LLC. | $162.52 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $63.21 | 1 | Exact Sciences Corporation ($63.21) |
| 2021 | $14.15 | 1 | Boston Scientific Corporation ($14.15) |
| 2019 | $558.83 | 41 | GlaxoSmithKline, LLC. ($66.79) |
| 2018 | $1,633 | 124 | AstraZeneca Pharmaceuticals LP ($292.98) |
| 2017 | $1,664 | 103 | AstraZeneca Pharmaceuticals LP ($237.88) |
All Payment Transactions
270 individual payment records from CMS Open Payments — Page 2 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/15/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Respiratory | ||||||
| 02/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 02/12/2019 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/12/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Neuroscience | ||||||
| 02/11/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Diabetes | ||||||
| 02/04/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/04/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/01/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: DIABETES | ||||||
| 01/31/2019 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Addiction Therapy | ||||||
| 01/28/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: Cardiovascular | ||||||
| 01/25/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, STEGLATRO | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/24/2019 | EISAI INC. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Nutrition and Weight Loss | ||||||
| 01/22/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Diabetes | ||||||
| 01/17/2019 | Aytu BioScience, Inc | Natesto (Drug) | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| Category: Urology | ||||||
| 01/17/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/08/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: RESPIRATORY | ||||||
| 01/04/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Diabetes | ||||||
| 12/18/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/13/2018 | West-Ward Pharmaceuticals | Mitigare (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/11/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: DIABETES | ||||||
| 12/04/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Gout/Rheumatology | ||||||
| 12/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 901 | 1,582 | $329,170 | $75,394 |
| 2022 | 12 | 914 | 1,585 | $278,311 | $74,900 |
| 2021 | 14 | 777 | 1,403 | $173,168 | $79,929 |
| 2020 | 15 | 729 | 1,224 | $126,801 | $57,325 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 341 | 806 | $221,650 | $40,930 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 197 | $37,430 | $8,809 | 23.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 100 | 100 | $13,500 | $7,193 | 53.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $16,500 | $7,072 | 42.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 110 | 110 | $6,050 | $3,616 | 59.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $8,400 | $1,961 | 23.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 18 | $10,260 | $1,932 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $6,300 | $1,835 | 29.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $1,375 | $821.75 | 59.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 58 | $3,770 | $582.24 | 15.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 42 | 43 | $1,935 | $509.63 | 26.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 96 | $1,440 | $75.49 | 5.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 17 | 56 | $560.00 | $56.74 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 377 | 837 | $186,775 | $41,967 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 180 | 258 | $41,530 | $12,112 | 29.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 78 | 78 | $10,140 | $5,258 | 51.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 21 | 21 | $5,250 | $5,136 | 97.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 88 | 88 | $4,735 | $2,831 | 59.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $11,143 | $2,407 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,500 | $2,363 | 36.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 37 | 37 | $1,585 | $1,185 | 74.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $7,018 | $956.41 | 13.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 50 | $2,480 | $552.59 | 22.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 17 | 72 | $555.00 | $88.62 | 16.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 64 | $600.00 | $43.72 | 7.3% |
About Dr. David Gehring, MD
Dr. David Gehring, MD is a Internal Medicine healthcare provider based in Woodbury, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740288091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Gehring, MD has received a total of $3,934 in payments from pharmaceutical and medical device companies, with $63.21 received in 2023. These payments were reported across 270 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,869).
As a Medicare-enrolled provider, Gehring has provided services to 3,321 Medicare beneficiaries, totaling 5,794 services with total Medicare billing of $287,549. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Woodbury, NJ
- Active Since 07/11/2005
- Last Updated 08/05/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740288091
Products in Payments
- FARXIGA (Drug) $266.33
- Trintellix (Drug) $260.84
- SYMBICORT (Drug) $244.13
- CHANTIX (Drug) $193.07
- JANUVIA (Drug) $157.93
- Uloric (Drug) $151.01
- Victoza (Drug) $146.87
- LINZESS (Drug) $113.25
- XIFAXAN (Drug) $104.13
- Prolia (Biological) $95.25
- Vascepa (Drug) $93.58
- SOLIQUA (Drug) $91.86
- Repatha (Biological) $91.75
- TOUJEO (Drug) $86.60
- MYRBETRIQ (Drug) $83.41
- Ozempic (Drug) $81.04
- XARELTO (Drug) $75.64
- Livalo (Drug) $73.26
- TRULICITY (Drug) $70.06
- ENTRESTO (Drug) $67.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Woodbury
Dr. Karen Schwartz, M.d, M.D
Internal Medicine — Payments: $393,480
Irina Murakhovskaya, M.d, M.D
Internal Medicine — Payments: $189,283
Bernard Quebral, Md, MD
Internal Medicine — Payments: $46,880
Anthony Bonett, Md, MD
Internal Medicine — Payments: $12,608
Dr. Linda Aquilino, D.o, D.O
Internal Medicine — Payments: $11,480
Dr. Richard Shaw, D.o, D.O
Internal Medicine — Payments: $3,270